Class IITerminatedD-0348-2023
Drug recall · March 1, 2023
Warfarin Sodium Tablets recall
Why: Failed Impurities/Degradation Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
- Lots / codes
Batch #: NB101596, Exp. 04/30/2023
- Quantity
- 12,216 bottles (100 count each)
- Company
- Rising Pharmaceuticals, East Brunswick, NJ
- Distribution
- Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
- Initiated
- February 15, 2023 · Voluntary: Firm initiated
- Classified
- February 23, 2023
- Reported
- March 1, 2023
- Ended
- June 14, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Warfarin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.